Expert oncologist Zofia Piotrowska, MD, reviews the case of a 59-year-old woman who is diagnosed and treated for EGFR exon 20–positive non–small cell lung cancer.
EP. 1: Expert Perspectives on a Case of Stage 4 NSCLC
Expert oncologist Zofia Piotrowska, MD, reviews the case of a patient managed with frontline chemotherapy after receiving a diagnosis of stage 4 NSCLC.
EP. 2: Novel Targeted Therapy for EGFR Exon 20–Positive NSCLC
Comprehensive insight on the two novel, targeted agents approved for the management of EGFR exon 20–positive NSCLC following frontline therapy.
EP. 3: Real-World Use of Targeted Agents in EGFR Exon 20–Positive NSCLC
Practical advice regarding the selection and management of amivantamab or mobocertinib in patients diagnosed with EGFR exon 20–positive NSCLC.
EP. 4: EGFR Exon 20–Positive NSCLC: Future Directions in Care
Before closing out her discussion on novel therapy for EGFR exon 20–positive NSCLC, Zofia Piotrowska, MD, shares her hopes for future developments in care.
2 Commerce Drive Cranbury, NJ 08512